MURRIETA, CALIF. (PRWEB) FEBRUARY 26, 2019
Murrieta Genomics, the genomic sequencing business incubator, has executed a Memorandum of Understanding with UC Riverside’s Research and Economic Development Office to assist researchers and entrepreneurs in developing and commercializing genomic-related applications in healthcare, agriculture and other areas of social importance.
The commercialization of intellectual property from universities is an ongoing challenge. This agreement is intended to facilitate the flow of ideas and research to the private sector through a structured framework that protects UC Riverside’s intellectual property.
Under the agreement, both parties will work together to commercialize genomic-related research and intellectual property developed by scientists at UC Riverside. Murrieta Genomics will provide specialized genomic sequencing services to UC Riverside staff and students along with training and mentorship. In addition, Murrieta Genomics will promote UC Riverside’s EPIC Small Business Development Center (EPIC SBDC) services to companies in the Murrieta Genomics incubator.
UC Riverside, through EPIC SBDC, will aid incubator companies and will facilitate introductions to faculty experts for collaboration. The university will also pair Murrieta Genomics with researchers working in various genomic fields for evaluation of potential commercial applications.
“UC Riverside is a virtual gold mine of intellectual property in the genomic area,” stated Jay Goth, a co-founder of Murrieta Genomics. “We have had initial discussions with several researchers and scientists at the university and are very excited to bring our network of industry leaders and entrepreneurs to the commercialization process.”
“The Murrieta Genomics team has built a genomic sequencing laboratory and assembled a strong advisory board to help researchers turn projects into companies,” said Rosibel Ochoa, associate vice chancellor for technology partnerships at UC Riverside. “This is a critical ingredient needed to spur advances in genomics from lab to market. As a leading agriculture and biomedical research organization we want to encourage partnerships that can address today’s challenges.”
The Murrieta Genomics team expects to work closely with EPIC SBDC. “As a former EPIC SBDC consultant and former Entrepreneur-in-Residence at UC Riverside, I know how incredibly important it is for startups to receive the right guidance,” continued Goth. “I look forward to bringing the rich intellectual property out of the labs, matching scientists together with proven entrepreneurs, and forming new successful biotechnology companies in the region. Genomic science is still in its early stages, and the opportunities are enormous.”
About Murrieta Genomics
Murrieta Genomics provides access to next generation sequencing technology for researchers in the health, veterinary, agriculture, forensics and direct to consumer industries. The company is a true business incubator, offering mentorship and guidance from both the scientific and business perspective to aspiring genomic-related entrepreneurs. The founders of Murrieta Genomics have extensive background in business, finance, science and technology. They are supplemented with a prestigious advisory board from both business and science. In addition to low-cost incubation, the company provides hands-on consulting and will provide seed funding to qualified incubator graduates and connections to next-stage funders. For more information visit http://www.murrietagenomics.com.
About the University of California, Riverside
The University of California, Riverside (http://www.ucr.edu) is a doctoral research university, a living laboratory for groundbreaking exploration of issues critical to Inland Southern California, the state and communities around the world. Reflecting California's diverse culture, UCR's enrollment is more than 24,000 students. The campus opened a medical school in 2013 and has reached the heart of the Coachella Valley by way of the UCR Palm Desert Center. The campus has an annual statewide economic impact of almost $2 billion. To learn more, email email@example.com.